Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.85 |
| ▸ | GAA | P10253 | 3/20 | 0.85 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.79 |
| ▸ | RAB9A | P51151 | 5/20 | 0.72 |
| ▸ | HPGD | P15428 | 3/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.72 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.63 |
| ▸ | NPC1 | O15118 | 2/20 | 0.62 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | ATM | Q13315 | 1/20 | 0.60 |
| ▸ | SCN1A | P35498 | 1/20 | 0.60 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.60 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3308284 | 0.98 | GAA (0.81) | MAPTGAAALDH1A1RAB9AHPGD | |
| SCHEMBL11341322 | 0.98 | GAA (0.81) | MAPTGAAALDH1A1RAB9AHPGD | |
| SCHEMBL27806510 | 0.98 | GAA (0.81) | MAPTGAAALDH1A1RAB9AHPGD | |
| SCHEMBL11340463 | 0.98 | GAA (0.81) | MAPTGAAALDH1A1RAB9AHPGD | |
| SCHEMBL11334339 | 0.98 | GAA (0.81) | MAPTGAAALDH1A1RAB9AHPGD | |
| Hydrochloric Acid SCHEMBL29096649 | 0.98 | GAA (0.81) | MAPTGAAALDH1A1RAB9AHPGD | |
| Water SCHEMBL27398863 | 0.98 | GAA (0.81) | MAPTGAAALDH1A1RAB9AHPGD | |
| Propionic Acid SCHEMBL11512001 | 0.96 | GAA (0.79) | MAPTGAAALDH1A1RAB9AHPGD | |
| Acetic Acid SCHEMBL28138148 | 0.96 | MAPT (0.79) | MAPTGAAALDH1A1RAB9AHPGD | |
| SCHEMBL19501437 | 0.92 | MAPT (0.79) | MAPTGAAALDH1A1RAB9AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1684 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122025690-A | Composite modified material of high-toughness graphite bipolar plate and preparation method thereof | 青岛高等密封制品有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-12340996-B2 | Method for rapid on-site detection of fentanyl analogs using a miniature mass spectrometer | CHINESE ACADEMY OF INSPECTION AND QUARANTINE (CN) | 2025-06-24 | — | — | US | claimed |
| CN-119612507-A | Preparation method and application of flexible graphite | 滨州双峰石墨密封材料有限公司 | 2025-03-14 | — | — | CN | claimed |
| US-20240415819-A1 | MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS | QLi5 Therapeutics AG (DE) | 2024-12-19 | — | — | US | claimed |
| CN-118086986-A | High-coverage electroplated copper additive composition for printed circuit board | 广东利尔化学有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-118063390-A | Diamine with naphthyridone structure, thermosetting polyimide resin and preparation method thereof | 西北工业大学 | 2024-05-24 | — | — | CN | claimed |
| CN-117623967-A | Preparation method of telmisartan intermediate 3-methyl-4-aminobenzoic acid | 迪嘉药业集团股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-114249533-B | Preparation method of graphene oxide glaze modified polished ceramic tile | 广西蒙娜丽莎新材料有限公司 | 2023-12-19 | — | — | CN | claimed |
| WO-2023218306-A1 | ANTITUMOR ACTIVITY OF MESO-(P-ACETAMIDOPHENYL)-CALIX[4]PYRROLE BY INHIBITION OF THE ENZYMATIC ACTIVITY OF THE PROTEIN GLYCYL-TRNA SYNTHASE 1 (GARS1) | Giam Pharma International sarl (CH) | 2023-11-16 | — | — | WO | claimed |
| CN-116535390-A | PH-sensitive 4-amide piperidine derivative, pharmaceutical composition, and preparation method and application thereof | 武汉思瓴生物科技有限公司 | 2023-08-04 | — | — | CN | claimed |
| EP-0202482-B1 | PHARMACOLOGICALLY ACTIVE PROPIONYLANILIDES | ERREGIERRE INDUSTRIA CHIMICA Spa (IT) | 1990-09-12 | — | — | EP | claimed |
| EP-0358571-A1 | Thioformamidines, their preparation and medical applications | PIERRE FABRE MEDICAMENT (FR) | 1990-03-14 | — | — | EP | claimed |
| EP-0358305-A1 | Mercapto-phenylalcanoylamino acid amides, their preparation and their use as collagenase inhibitors | BEECHAM GROUP PLC (GB) | 1990-03-14 | — | — | EP | claimed |
| US-4639449-A | TREATMENT OF COLD SYMPTOMS | ERREGIERRE INDUSTRIA CHIMICA SPA (IT) | 1987-01-27 | — | — | US | claimed |
| EP-0202482-A1 | Pharmacologically active propionylanilides | ERREGIERRE INDUSTRIA CHIMICA Spa (IT) | 1986-11-26 | — | — | EP | claimed |
| US-4435419-A | Method of treating depression using azabicyclohexanes | AMERICAN CYANAMID COMPANY (US) | 1984-03-06 | — | — | US | claimed |
| US-4178383-A | Fungicidally active oxime-ethers of isonitrosocyanoacetamides | BAYER AKTIENGESELLSCHAFT (DE) | 1979-12-11 | — | — | US | claimed |
| US-4100351-A | Method for preparing aromatic urethans | ANIC, S.P.A. (IT) | 1978-07-11 | — | — | US | claimed |
| US-4096333-A | NITROSATION OF A 2-METHYLACETANILIDE | TENNECO CHEMICALS, INC. (US) | 1978-06-20 | — | — | US | claimed |
| US-4054548-A | Pottery-like mending composition | MALONE LAURENCE A | 1977-10-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240415819-A1 | MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS | PSMB5, PSMA5, PSMB1 | MAPT 1884/4885GAA 362/4885ALDH1A1 3140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.